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The absence of urban yellow fever virus (YFV) in
Bolivian cities has been attributed to the lack of competent
urban mosquito vectors. Experiments with Aedes aegypti
from Santa Cruz, Bolivia, demonstrated infection (100%),
dissemination (20%), and transmission of a Bolivian YFV
strain (CENETROP-322). 
Y
ellow fever virus (YFV) may cause severe hemor-
rhagic fever in humans. The virus is transmitted
between susceptible vertebrate hosts by infected mosqui-
toes in the genera Aedes, Haemagogus, or Sabethes (1). In
the Americas, YFV occurs in two transmission cycles. In
the jungle/sylvatic cycle, the virus is transmitted between
susceptible monkeys, and possibly other vertebrates, by
tree-hole–breeding mosquitoes (1). Jungle yellow fever
(YF) cases occur when these infected vectors feed on sus-
ceptible humans. In the urban cycle, YFV is transmitted to
humans by Aedes aegypti mosquitoes (1). In 2003, a total
of 226 cases of jungle YF were reported from South
America to the Pan American Health Organization, and as
of June 23, ongoing outbreaks in Bolivia, Brazil,
Colombia, and Peru during 2004 have thus far resulted in
86 confirmed cases and 41 deaths (2). 
An Ae. aegypti eradication campaign initiated by the
Pan American Sanitary Bureau in 1947 eliminated this
species from most of Central and South America, and
urban YF disappeared from the Americas in the 1940s.
However, during the past 20 years, many countries aban-
doned Ae. aegypti control measures, and this urban vector
now reoccupies almost the entire area of its distribution
preeradication (1). Ae. aegypti was eradicated from
Bolivia during the 1960s and 1970s but reappeared in the
city of Santa Cruz in 1980, and epidemics of dengue fever
occurred during the 1980s and 1990s (3). In 1997 to 1998,
six cases of YF were reported among Santa Cruz residents,
and some were regarded as urban YF cases (3); despite a
population >1 million, low vaccine immunization cover-
age, and the presence of Ae. aegypti (3), no urban YF out-
break occurred. Based on these observations, researchers
have suggested that sylvan strains of YFV circulating in
Bolivia may not be infective for Bolivian Ae. aegypti. This
study examined that hypothesis and the infectivity of a
Bolivian strain of YFV for Bolivian Ae. aegypti.
The Study
All work involving infectious YFV was performed in
biosafety level 3 facilities at the University of Texas
Medical Branch. Three human isolates of YFV were used:
CENETROP-322 (La Paz Department, Bolivia, 1999),
Jimenez (Panama, 1974), and Asibi (Ghana, 1927). To
facilitate transmission from a viremic vertebrate, viruses
were adapted by serial passage through Syrian golden
hamsters (Mesocricetus auratus), following the model of
Tesh et al. (4,5); CENETROP-322 and Jimenez were pas-
saged 11 times, and the Asibi strain was passaged 10 times.
The SC strain of Ae. aegypti was started with mosqui-
toes collected from Santa Cruz, Bolivia, in 2001.
Mosquitoes used in this experiment were from laboratory-
reared F2-F3 generation. The REX-D strain, an old labora-
tory colony originally started with mosquitoes collected in
Rexville, Puerto Rico and of previously defined suscepti-
bility to YFV infection (6) was used as a control.
Mosquitoes were maintained as previously described (7).
Three hamsters were injected intraperitoneally (IP)
with 100 µL of clarified liver homogenate, which con-
tained approximately 106 log10 tissue culture infectious
dose 50% (TCID50/mL) of each YFV strain. Three days
after infection, when viremia levels have been shown to
peak (4), hamsters were anesthetized (50 mg Pentobarb/kg
IP) and simultaneously exposed to 10-day-old Ae. aegypti
SC or REX-D mosquitoes for 1 h. Fully engorged mosqui-
toes in each group were placed in separate cages and incu-
bated for 15 days at 28°C and 80% relative humidity on a
diet of 10% sucrose. Hamster blood samples were collect-
ed immediately afterward and stored at –80°C for viral
assay.
Virus Transmission 
At day 15 after infection, mosquitoes were allowed to
feed on 8-day-old mice. (Mice were used in preference to
adult hamsters because they are more susceptible to fatal
infection.) After feeding, mosquitoes were assayed for
YFV infection and dissemination by whole-body titration
and immunofluorescence assay (IFA) of head-squash
material, respectively (7). For IFA, a broadly reactive anti-
flavivirus monoclonal antibody (813) with biotin-strepta-
vidin amplification was used (8). Suckling mice were
observed for illness and death. The brains of two paralyzed
mice were tested for viral antigen by culturing on Vero
cells. At day 14 after exposure, serum specimens from
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hemagglutination inhibition (HI) test (9). 
All three strains of YFV caused viremia in hamsters on
day 3 after infection, with titers of 8.5, 8.7, and 7.3
TCID50log10/mL (CENETROP-322, Jimenez, and Asibi,
respectively), as determined by assay in mosquito cell cul-
tures (4). Determination of mosquito infection and dissem-
ination rates showed that all YFV strains were able to
infect both strains of Ae. aegypti, although infection rates
varied from 15.1% to 100%. Mean total mosquito YFV
titers were relatively low, but the presence of virus after 15
days, evidence of dissemination in the insect, and trans-
mission data are all indicative of replication. At day 15
postinfection, 100% of SC Ae. aegypti were infected with
CENETROP-322. Infection rates and mean viral titers for
CENETROP-322 were higher in SC Ae. aegypti than in the
REX-D strain (Table 1). Infection rates of CENETROP-
322 and Jimenez were higher than the rate for Asibi in both
mosquito strains. 
Virus titers in the mosquitoes varied considerably but
were lowest in REX-D strain insects infected with
CENETROP-322 (Table 1). These mosquitoes had the
highest dissemination rates (80.7%), which indicates little
correlation between virus titer and dissemination rates.
Dissemination rates were highest in the REX-D strain; but
our data demonstrate that both Panamanian and Bolivian
strains of YFV disseminated in Santa Cruz Ae. aegypti
(Table 1).
Transmission trials used 8-day-old mice to feed mos-
quitoes that had ingested YFV 15 days earlier (Table 2).
Five mice were used per virus strain. The reluctance of
mosquitoes to feed on suckling mice precluded an evalua-
tion of all YFV-mosquito combinations. However, HI
results indicated that antibodies against YFV (320 titer,
Table 2) developed in one mouse exposed to SC mosqui-
toes infected with CENETROP-322, which indicated
transmission by the Bolivian Ae. aegypti. In addition,
Jimenez and Asibi strains of YFV were transmitted by the
REX-D mosquitoes. Transmission was confirmed by
recovering YFV by culture from dead mice. 
Conclusions
Susceptibility to YFV infection is highly variable in
mosquitoes from different locations (10–12) and may be
influenced by selection (6) and colonization (13).
Although the use of Bolivian mosquitoes with few labora-
tory-reared generations compromised our ability to use
large numbers, obtaining competence data as possibly rep-
resentative of wild, noncolonized, mosquitoes was impor-
tant. Dissemination and transmission by Santa Cruz Ae.
aegypti indicate their ability to serve as vectors for a
Bolivian strain of YFV.  A critical component of this study
was the use of a hamster model for YFV (4). The high
viremia levels in hamsters (4,5) facilitate oral infection of
mosquitoes and more closely resemble natural infection
than feeding the insects on artificial blood meals. Suckling
mice remain useful because of their sensitivity to YFV
infection. 
We could argue that by passing the virus in hamsters,
the virus phenotype may be altered with respect to vector
infectivity. However, after equivalent passages, the infec-
tivity of the Bolivian, Panamanian, and African strains dif-
fered. The Jimenez strain was highly infectious for
Bolivian Ae. aegypti (93.5%), with a relatively high dis-
semination rate (34.5%). In contrast, the Asibi was rela-
tively noninfectious for the Bolivian mosquitoes.
Considering the numbers of mosquitoes and virus strains
involved, we cannot conclude that this finding reflects a
general trend of incompatibility between South American
Ae. aegypti and YFV of African origin. However, the
results obtained are in close agreement with the findings
by Tabachnick et al. (12). Johnson et al. (14), using
Brazilian strains of Ae. aegypti and YFV, reported similar
results of 35% infection rates and 25% dissemination rates.
Lourenço-de-Oliveira et al. (11,15) observed infection
rates from 0% to 48.6% in Brazilian Ae. aegypti infected
with Brazilian YFV. In comparison, we found higher infec-
tion rates for Panamian and Bolivian YF viruses
(63.3%–100%), but this finding may reflect our use of a
viremic animal to infect the mosquitoes, whereas
Tabachnick et al. (12) and Johnson et al. (14) used artifi-
cially prepared blood meals. Our results also demonstrate
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Table 1. Infection, dissemination, and virus titers for three strains of yellow fever virus, CENETROP-322, Jimenez, and Asibi, in two 
strains of Aedes aegypti mosquitoes, Santa Cruz and REX-D, at day 15 postinfection
a  
Ae. aegypti  Virus strain 
Hamster serum titer 
(TCID50 log10/mL) 
No. infected by 
titration (5%) 
Mean titer of positives 
(TCID50 log10/mL) 
Dissemination rate 
by IFA (%) 
Santa Cruz  CENETROP-322  8.5  10/10 (100)  3.5  20 
Santa Cruz  Jimenez  8.7  29/31 (93.5)  3.5  34.5 
Santa Cruz  Asibi  7.3  3/26 (15.1)  3.5  0 
REX-D CENETROP-322 8.5  19/30  (63.3)  1.5  80.7 
REX-D Jimenez 8.7  27/30  (90)  3.5  73.4 
REX-D Asibi 7.3  13/30  (43.3)  4.0 38.4 
aTCID50, tissue culture infectious dose 50%; IFA, immunofluorescence assay. 
 that passaging YFV in hamsters does not compromise the
ability of the virus to infect mosquitoes and that the ham-
ster model is useful to study mosquito competence for
YFV. 
In conclusion, our results do not support the hypothesis
that Bolivian strains of YFV cannot infect Bolivian Ae.
aegypti and demonstrate that the recolonizing (after 1980)
South American strains of Ae. aegypti are potential YFV
vectors. The reason urban YF epidemics have not yet
occurred in South America, including in the city of Santa
Cruz, Bolivia, where some cases were recently reported
within the city limits (3), is still unknown. The mosquito
infection rates observed in our study were higher that those
reported by Lourenço-de-Oliviera et al. (11), and we also
demonstrated YFV transmission (albeit at a low level).
Thus, if YFV were to be reintroduced into urban areas of
South America, a transmission cycle could possibly be
established. The absence of epidemic YF may be the result
of other factors, including widespread deforestation and
less opportunity for YFV to move out of the sylvatic cycle,
better mosquito control, the local population’s YFV vac-
cine status, and, possibly, heterologous antibodies to other
flaviviruses such as dengue (5). 
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Table 2. Transmission of yellow fever virus by infected Aedes aegypti mosquitoes to suckling mice
a 
HI titer for 4 U of antigen 
Ae. aegypti strain  Virus strain 
No. mice infected/ 
No. exposed (%)  YFV SLEV  WNV 
0 0  0 
0 0  0 
320 0 0 
0 0  0 
Santa Cruz-  CENETROP-322  1/5 (20)
b 
0 0  0 
NT NT  NT 
NT NT  NT 
NT NT  NT 
NT NT  NT 
REX-D Jimenez  4/5  (80)
c 
NT NT  NT 
160 0 0 
0 0  0 
0 0  0 
80 0  0 
REX-D Asibi  3/5  (60)
b 
40 0  0 
aHI, hemagluttination-inhibition; YFV, yellow fever virus; SLEV, St. Louis encephalitis virus; WNV, West Nile virus; NT, not tested. 
bInfection determined by presence of anti-YF antibodies in mice sera (HI test). 0 indicates a titer of 1:20. 
cInfection determined by death/virus detection for suckling mice. 12. Tabachnick WJ, Wallis GP, Aitken THG, Miller BR, Amato GD,
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